Poland· PL-100411711

Efavirenz + Emtricitabine + Tenofovir disoproxil Aurovitas

A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenzum + emtricitabinum + tenofovirum disoproxilum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR06

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about efavirenzum + emtricitabinum + tenofovirum disoproxilumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search emtricitabine, tenofovir disoproxil and efavirenz products by name

Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)

Active substance: Efavirenzum + Emtricitabinum + Tenofovirum disoproxilum
Manufacturer: Aurovitas Pharma Polska Sp. z o.o.
Country: Poland (PL)
ATC code: J05AR06
ATC class: Emtricitabine, tenofovir disoproxil and efavirenz
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 6

gtin
05909991458010
gtin
05909991458027
gtin
05909991458034
gtin
05909991458041
gtin
05909991458058
gtin
05909991458065

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check emtricitabine, tenofovir disoproxil and efavirenz against other medicines How interaction checks work

Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Emtricitabine, tenofovir disoproxil and efavirenz in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir disoproxil and efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
Finland · Fatrino
France · Efavirenz/Emtricitabine/Tenofovir Disoproxil Arrow, Efavirenz/Emtricitabine/Tenofovir Disoproxil Bgr
United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/0e404b49-f9e0-48f6-8258-375e26fc2029
GET /v1/drugs/0e404b49-f9e0-48f6-8258-375e26fc2029?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "600 mg + 200 mg + 245 mg",
  "packaging": "05909991458010 ¦ Rpz ¦ 140837\n30 tabl. w blistrze\n05909991458027 ¦ Rpz ¦ 140838\n90 tabl. w blistrze\n05909991458034 ¦ Rpz ¦ 140839\n90 tabl. w blistrze\n05909991458041 ¦ Rpz ¦ 140840\n90 tabl. w butelce\n05909991458058 ¦ Rpz ¦ 140841\n30 tabl. w butelce\n05909991458065 ¦ Rpz ¦ 140842\n30 tabl. w blistrze",
  "substance": "Efavirenzum 600 mg + Emtricitabinum 200 mg + Tenofovirum disoproxilum 245 mg",
  "common_name": "Efavirenzum + Emtricitabinum + Tenofovirum disoproxilum",
  "pl_product_id": "100411711",
  "pozwolenie_nr": "26801",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about emtricitabine, tenofovir disoproxil and efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console